Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OKITASK for acute pain after molar extraction
NCT03836807Phase 3Completed
- Sponsor
- Dompé
- Start
- Apr 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute pain comparing OKITASK with Placebo (2 arms). Primary endpoint: Area Under the Curve of Pain Intensity from 0 to 6 hours. Started Apr 2018; status: completed.
02
Drugs
ketoprofen lysine salt
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03836807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03836807.